Where I see patients (2)
My reviews
Selected research
-
HER2 overexpression in urothelial carcinoma with GATA3 and PPARG copy number gains.
The oncologist
-
Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT Trial.
Clinical cancer research : an official journal of the American Association for Cancer Research
-
CDK12 Loss Promotes Prostate Cancer Development While Exposing Vulnerabilities to Paralog-Based Synthetic Lethality.
bioRxiv : the preprint server for biology
Contact me
- Request appointment
- Refer a patient
- (415) 476-4616
4.9